Cases filed in the Third Circuit Courts
Cases 11 - 20 of 358
IVERS v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv21150
Plaintiff: ANTHONY IVERS
Defendant: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., ARROW PHARM (MALTA) LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MANTALIS v. AUROBINDO PHARM, LTD. et al
as 1:2023cv14463
Plaintiff: STELIOS MANTALIS
Defendant: AUROBINDO PHARM, LTD., HETERO DRUGS LTD., HETERO LABS LTD. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Astellas Pharma Inc. et al v. Sandoz Inc. et al We have downloadable decisions or orders for this case
as 1:2020cv01589
Defendant: Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff: Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BUXTON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02933
Plaintiff: DIXIE B BUXTON
Defendant: AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HAUGHTON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03646
Plaintiff: OCIE MAE HAUGHTON
Defendant: AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, ARROW PHARM (MALTA) LTD. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
FANNING v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03540
Plaintiff: LINDA FANNING
Defendant: AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROLIFE PHARMA, LLC and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MERRILL v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02857
Plaintiff: DOUGLAS MERRILL
Defendant: AUROBINDO PHARMA, LTD., HETERO DRUGS, LTD., HETERO LABS, LTD. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WESSON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02342
Plaintiff: EMMETT WESSON
Defendant: AUROBINDO PHARMA LTD., HETERO DRUGS LTD., HETERO LABS, LTD. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Valsartan Losartan and Irbesartan Products
as 23-8005
Not Classified By Court: In re: IN RE: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Petitioner: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC, PRINSTON PHARMACEUTICAL INC and others
Respondent: CONSUMER ECONOMIC LOSS PLAINTIFFS, THIRD-PARTY PAYOR PLAINTIFFS and MEDICAL MONITORING PLAINTIFFS
Not Yet Classified: PRODUCT LIABILITY ADVISORY COUNCIL INC
FARAGI v. HETERO DRUGS, LTD. et al
as 1:2023cv01166
Plaintiff: ETHEL FARAGI
Defendant: HETERO DRUGS, LTD., HETERO LABS, LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD. and others
In Re: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?